CureVac Financial Statements From 2010 to 2025
| 5CV Stock | EUR 2.78 0.03 1.07% |
Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as , as well as many indicators such as . CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
CureVac |
CureVac NV Company Current Valuation Analysis
CureVac NV's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CureVac NV Current Valuation | 792.23 M |
Most of CureVac NV's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CureVac NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CureVac NV has a Current Valuation of 792.23 M. This is 94.48% lower than that of the Healthcare sector and 82.95% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 95.23% higher than that of the company.
CureVac NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CureVac NV's current stock value. Our valuation model uses many indicators to compare CureVac NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CureVac NV competition to find correlations between indicators driving CureVac NV's intrinsic value. More Info.CureVac NV is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CureVac NV's earnings, one of the primary drivers of an investment's value.About CureVac NV Financial Statements
CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's revenue or net income, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. CUREVAC N operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 455 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out the analysis of CureVac NV Correlation against competitors. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..